Roche Fuzeon Approval Presents Challenges Of Reimbursement, Supply
Executive Summary
AIDS Drug Assistance Program coverage of Roche's antiretroviral Fuzeon could hinge upon the agent's role as either replacement or add-on therapy
You may also be interested in...
Bristol Will Use One Distributor To Ensure Patient Access For Orencia Launch
Bristol-Myers Squibb is launching its rheumatoid arthritis treatment Orencia (abatacept) through a sole distributor to ensure patient access while the firm works to expand its manufacturing capacity
Bristol Will Use One Distributor To Ensure Patient Access For Orencia Launch
Bristol-Myers Squibb is launching its rheumatoid arthritis treatment Orencia (abatacept) through a sole distributor to ensure patient access while the firm works to expand its manufacturing capacity
Gilead Leads Biotech Rebound In 2003: Product Stories Play Well
Gilead Sciences is leading a new wave of biotech stocks attempting to break out of the start-up phase to become full-fledged biopharma companies